Olga Golubnitschaja
Pessimistic versus optimistic prognosis is considered for the healthcare systems worldwide depending on the paradigm which medical survices will apply over the next 2 decades. Current healthcare deals with dramatic problems created by the concept of delayed (or reactive) medical approaches resulting in a low cost effectiveness of treatments and outcomes considered as inadequate for many acute and chronic pathologies. In contrast, Predictive Preventive and Personalised Medicine (PPPM) is the new philosophy utilising an integrative concept of medical services that enables to predict individual predisposition before onset of the disease, to provide targeted preventive measures and create personalised treatment algorithms tailored to the person. The optimistic outcomes by PPPM are well justified as promoting healthcare sector by following measures: effective prevention early in life, identification of persons at-risk, patients’ stratification, optimal therapy planning, prediction and reduction of adverse drug-drug or drug-disease interactions, etc. Emerging technologies, such as omics, medical imaging, pharmacogenetics, pathology-specific patterns of biomarkers, disease modelling, individual patient profiles, etc. are expected to play a pivotal role in the advancing of medical services. Being at the forefront of this process, the European Association for Predictive, Preventive and Personalised Medicine promotes the integrative concept of PPPM among professionals, governmental institutions, funding bodies, patient organisations and in the public domain. An integrative approach by PPPM is considered as the medicine of the future.
इस लेख का हिस्सा